2020 GeneSystems, Inc.:企業のM&A・提携動向(医療機器分野)

◆英語タイトル:2020 GeneSystems, Inc. - Medical Equipment - Deals and Alliances Profile
◆商品コード:GDME2062D
◆発行会社(調査会社):GlobalData
◆発行日:2016年2月23日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

20/20 GeneSystems, Inc. (20/20 Gene) is a medical diagnostic company that develops and commercializes diagnostic tests and proteomics products for early disease detection, therapy selection and biodefense applications. It offers tests in the areas such as personalized medicine, early detection of lung cancer, and biological detection. 20/20 Gene’s blood test technology is used in the early detection of lung cancer and provides method for analysis of cell signaling in tissue and technologies to detect biological toxins. It offers its products and services to drug companies, biodefense specialists and life scientists for protein analysis. 20/20 Gene is headquartered in Rockville, Maryland, the US.

2020 GeneSystems, Inc. – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
20/20 GeneSystems, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 5
20/20 GeneSystems, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 6
20/20 GeneSystems, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 7
20/20 GeneSystems, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 8
20/20 GeneSystems, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 9
20/20 GeneSystems, Inc., Medical Equipment, Deal Details 10
Venture Financing 10
20/20 GeneSystems Raises USD4.5 Million in Series A Financing 10
20/20 Gene Systems Raises USD1 Million in Financing Round 11
20/20 GeneSystems To Raise US$5 Million In Venture Financing 12
20/20 GeneSystems, Inc. – Key Competitors 13
Key Employees 14
Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
20/20 GeneSystems, Inc., Medical Equipment, Key Facts 1
20/20 GeneSystems, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 1
20/20 GeneSystems, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 5
20/20 GeneSystems, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 6
20/20 GeneSystems, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 7
20/20 GeneSystems, Inc., Deals By Market, 2010 to YTD 2016 8
20/20 GeneSystems, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 9
20/20 GeneSystems Raises USD4.5 Million in Series A Financing 10
20/20 Gene Systems Raises USD1 Million in Financing Round 11
20/20 GeneSystems To Raise US$5 Million In Venture Financing 12
20/20 GeneSystems, Inc., Key Competitors 13
20/20 GeneSystems, Inc., Key Employees 14

List of Figures
20/20 GeneSystems, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 1
20/20 GeneSystems, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 1
20/20 GeneSystems, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 1
20/20 GeneSystems, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 1
20/20 GeneSystems, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 5
20/20 GeneSystems, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 6
20/20 GeneSystems, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 7
20/20 GeneSystems, Inc., Medical Equipment, Deals by Market, 2010 to YTD 2016 8

★海外企業調査レポート[2020 GeneSystems, Inc.:企業のM&A・提携動向(医療機器分野)]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cosmo Pharmaceuticals NV (COPN):医療機器:M&Aディール及び事業提携情報
    Summary Cosmo Pharmaceuticals NV (Cosmo) is a pharmaceutical company that develops drugs for the treatment of gastro-intestinal diseases. The company develops its pharmaceutical products based on its multi matrix technology. Its proprietary clinical development pipeline intended for the treatment of …
  • Evertec, Inc. (EVTC):企業財務及び戦略的SWOT分析
    Summary Evertec, Inc. (Evertec) is a technology and communication company that offers transaction processing services. The company’s services include payment processing, merchant acquiring and business process management. Its payment processing services comprise card issuing and acquiring processing …
  • Expro International Group PLC:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Expro International Group PLC M …
  • ION Geophysical Corporation (IO)-石油・ガス分野:企業M&A・提携分析
    Summary ION Geophysical Corporation (ION) is a provider of seismic solutions. It offers advanced seismic data acquisition equipment, software, and seismic processing and planning services to the global oil and gas industry. The company acquires, process and interpret seismic data from seismic survey …
  • Unchained Labs-製薬・医療分野:企業M&A・提携分析
    Summary Unchained Labs is a life science tools company which offers protein stability assessment products for biologics. Its product portfolio includes UNcle (biologics stability platform), HUNK (aggregation predictor), pUNk (protein sizing system), GRUNT (automated formulation preparation system), …
  • Cue Energy Resources Limited (CUE):企業概要、財務及び戦略的SWOT分析
    Summary Cue Energy Resources Limited (Cue Energy) is an oil and gas company. The company explores, develops, and produces hydrocarbons. It has projects in Papua New Guinea, Indonesia, Australia and New Zealand. The company owns interests in five exploration permits in the Carnarvon Basin, offshore W …
  • The Sports Authority, Inc. (Inactive):企業の戦略・SWOT・財務分析
    SummaryThe Sports Authority, Inc. (Inactive) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of th …
  • Premier Marketing Public Company Limited:企業の戦略・SWOT・財務分析
    SummaryPremier Marketing Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of …
  • Ethicon US LLC:企業の戦略的SWOT分析
    Ethicon US LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Ogeda SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Ogeda SA (Ogeda), formerly Euroscreen SA, a subsidiary of Astellas Pharma Inc, is a clinical-stage drug discovery company that invents and develops fezolinetant and small molecule drugs targeting G-protein coupled receptors. The company discovers and develops drugs that treat hormone-depende …
  • Washington University in St Louis:医療機器:M&Aディール及び事業提携情報
    Summary Washington University in St Louis (WUSTL), a subsidiary of University of Washington is an educational university which provides education and research services. The university provides various courses of bachelor’s, master’s, and doctoral degrees in a wide range of traditional and interdisci …
  • Biotronik SE & Co KG:企業の戦略的SWOT分析
    Biotronik SE & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Silicor Materials Inc.:企業のM&A・提携動向(エネルギー分野)
    Summary Silicor Materials Inc. (Silicor Materials), formerly CaliSolar, Inc. is a renewable energy company that manufactures solar silicon and aluminum-based products. The company’s aluminum products include master alloys, which are used for automotive supply products; and polyaluminum chloride, whi …
  • Time Dotcom Berhad (TIMECOM):企業財務及び戦略的SWOT分析
    Summary Time Dotcom Berhad (Time) is a telecommunication service provider that provides data-centric, fixed-line telecommunication services to enterprises and corporations. The company provides services such as cross peninsular cable system, data, voice, internet, and enhanced services. Time offers …
  • Copperbelt Energy Corporation PLC (CEC)-エネルギー分野:企業M&A・提携分析
    Summary Copperbelt Energy Corporation PLC (CEC) is an electric utility that generates, transmits, distributes and sells energy. The company generates electricity from hydro, solar, gas and thermal sources; transmits electricity through a network of transmission lines and high voltage substations and …
  • Interface Biologics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Interface Biologics Inc (IBI) is a medical device company that develops transformative biomedical polymer technologies. The company offers anti-thrombogenic and combination drug delivery devices. Its anti-thrombogenic additives reduce thrombosis in blood contacting medical devices and polyme …
  • Dong Nai Paint Corporation (SDN):企業概要、財務及び戦略的SWOT分析
    Summary Dong Nai Paint Corporation (DNPC) is a paint manufacturing company. The company manufactures and distributes paints and related products. Its products include water based DONASA, solvent based DONA, heat insulation SUN-MASTER, (wall) putty DONASA, and expoxy, polyurethance paint. DNPC produc …
  • iRobot Corporation (IRBT):企業の財務及び戦略的SWOT分析
    iRobot Corporation (IRBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • 23andMe Inc:医療機器:M&Aディール及び事業提携情報
    Summary 23andMe Inc (23andMe) is a biotechnology research and information provider that offers tools for health and ancestry care. The company offers raw genetic data and ancestry-related genetic reports. Its service portfolio includes clinical development, research and development, ancestry service …
  • National Comprehensive Cancer Network-製薬・医療分野:企業M&A・提携分析
    Summary National Comprehensive Cancer Network (NCCN) is a contract research organization that offers clinical services. The organization offers research and medical information to help patients and health professionals related to cancer care. It provides subscriptions and products which include NCCN …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆